Lajos Pusztai
Emory University(US)University of California, San Francisco(US)Yale Cancer Center(US)Yale University(US)University of New Haven(US)Smilow Cancer Hospital(US)
Publications by Year
Research Areas
Breast Cancer Treatment Studies, HER2/EGFR in Cancer Research, Cancer Genomics and Diagnostics, Cancer Immunotherapy and Biomarkers, Advanced Breast Cancer Therapies
Most-Cited Works
- → Pembrolizumab for Early Triple-Negative Breast Cancer(2020)2,940 cited
- → Response to Neoadjuvant Therapy and Long-Term Survival in Patients With Triple-Negative Breast Cancer(2008)2,876 cited
- → Development and validation of a clinical cancer genomic profiling test based on massively parallel DNA sequencing(2013)2,153 cited
- → Breast Cancer Molecular Subtypes Respond Differently to Preoperative Chemotherapy(2005)1,881 cited
- → Measurement of Residual Breast Cancer Burden to Predict Survival After Neoadjuvant Chemotherapy(2007)1,626 cited
- → Gene-Expression Signatures in Breast Cancer(2009)1,493 cited